B LYMPHOBLASTIC LYMPHOMA
Clinical trials for B LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for older blood cancer patients
Disease control OngoingThis study compares a new combination of a targeted drug (inotuzumab) plus chemotherapy against standard chemotherapy alone in older adults with B-cell acute lymphoblastic leukemia or lymphoma. The targeted drug attaches to cancer cells and delivers a toxin to kill them. The goal…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
New drug combo shows promise against childhood leukemia in massive trial
Disease control OngoingThis large phase 3 trial studies whether adding the drug blinatumomab to standard chemotherapy can better treat newly diagnosed B-cell leukemia or lymphoma in children and young adults, including those with Down syndrome. The study involves over 6,700 participants and assigns dif…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 01, 2026 17:53 UTC